PROTAC BET Degrader-1 is primarily used in research to target and degrade BET proteins, which play a critical role in regulating gene expression. It is employed in studies focusing on cancer, inflammation, and other diseases where BET proteins are implicated. This compound helps researchers understand the biological functions of BET proteins and their potential as therapeutic targets. It is particularly useful in developing novel strategies for treating conditions driven by abnormal gene expression, such as certain cancers. Its application in preclinical studies aids in evaluating the efficacy of targeted protein degradation as a therapeutic approach.